nec 1

Necrostatin-1 (Nec-1) is a specific RIP1 inhibitor and necrotic apoptosis inhibitor, which inhibits TNF-α-induced necrotic apoptosis and also inhibits IDO.

Necrostatin 2 racemate (Necrostatin-2 racemate) is an potent and specific inhibitor of RIPK1.

Cl-Necrostatin-1 is an inhibitor of receptor-interacting protein kinase. It inhibits RIPK1 activity.

Necrostatin-1 (Nec-1) (inactive control), an inactive analog of Necrostatin-1, functions as a potent inhibitor of necroptosis [1].

Thalidomide-amine-C11-acid is an E3 ligase ligand-linker conjugate composed of Thalidomide 5-fluoride and a linker. This compound is utilized in the synthesis of JQAD1.

Piperazine-CO-C1-Azacyclohexane-C1-Piperazine is a PROTAC linker used in the synthesis of PROTACs, such as the PROTAC CDK4/6/9 degrader 1.

Thalidomide-OCH2-amide-PEG2-C2-Boc is an E3 ligase ligand-linker conjugate that includes a cereblon (CRBN) ligand for the E3 ubiquitin ligase and a linker. Thalidomide-OCH2-amide-PEG2-C2-Boc is utilized in the synthesis of PROTAC CDK4/6/9 degrader 2.

Lenalidomide 5'-piperazine-C1-piperidine hydrochloride is an E3 ligase ligand-linker conjugate that comprises a CRBN-based ligand and a linker, intended for use in synthesizing PROTACs.

Lenalidomide 5'-piperazine-C1-piperidine is an E3 ligase ligand-linker conjugate, which incorporates a CRBN-based ligand and a linker. It is suitable for synthesizing PROTAC.

L-threo-Sphingosine C-18 is a protein kinase C inhibitor.

Lysophosphatidylcholine C19:0 (1-Nonadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine), an acyl chain lipid, enhances IL-1beta secretion [1].

Sphingosine (d18:1), an amino alcohol, is chiefly recognized for its 18-carbon unsaturated hydrocarbon chain. Nevertheless, in mammalian tissues, both sphingosine and its variant, dihydrosphingosine, feature hydrocarbon chains ranging from 12 to 26 carbons. Sphingosine (d15:1) represents a naturally rare variant, serving as an internal standard for chromatographic or spectrometric analyses of sphingoid compounds.

Sphingosine (d16:1), an unconventional sphingolipid, is synthesized through enzymatic reactions starting with the condensation of myristoyl-CoA and serine by serine palmitoyltransferase long-chain base subunit 3 (SPTLC3), which shows a preference for myristoyl-CoA. This compound is found in minute quantities in its free form in human plasma and as a component of various plasma sphingolipids, such as sphingosine-1-phosphate, ceramides, sphingomyelins, and in brain cerebrosides, albeit at lower concentrations than the more common d18:1 sphingoid base. Sphingosine (d16:1) acts as an inhibitor of PKC in mixed micelle assays and diminishes superoxide production triggered by phorbol 12-myristate 13-acetate in isolated human neutrophils, as well as inhibiting the growth of CHO cells with IC50 values of 1 and 3.2 µM, respectively. Additionally, the concentration of sphingolipids containing sphingosine (d16:1) in the plasma is linked to the dietary consumption of saturated fatty acids and protein among ethnic Chinese populations.

18:0-LPS (Lysophosphatidylserine C18:0) is an endogenous lipid identified during the oxidation of phospholipids. It holds potential for use in cardiovascular disease research.

Nec-4 is a potent inhibitor of receptor interacting protein 1 (RIP1)(IC50 of 2.6 μM),and is a tricyclic derivative.